E-LIB Suche - Ergebnisse für: Dalal, Rahul S

1

Sa1829 IDENTIFYING PREDICTORS OF INFLAMMATORY MUSCULOSKELET..:

Hong, Simon J. ; Dalal, Rahul S. ; Kuhn, Kristine A....
Gastroenterology. 166 (2024) 5 - p. S-540 , 2024

Link: https://doi.org/10.1016/..

2

Sa1912 FECAL MICROBIOTA TRANSPLANTATION IN COMBINATION WITH..:

Allegretti, Jessica R. ; Axelrad, Jordan E. ; Dalal, Rahul S....
Gastroenterology. 166 (2024) 5 - p. S-576 , 2024

Link: https://doi.org/10.1016/..

3

Clinical Outcomes at 8-16 Weeks After Upadacitinib Initiati..:

Dalal, Rahul S ; Winter, Rachel W ; Gupta, Sanchit...
Inflammatory Bowel Diseases. 30 (2024) 6 - p. 1042-1043 , 2024

Link: https://doi.org/10.1093/..

4

Sa1830 INFLAMMATORY MUSCULOSKELETAL SYMPTOMS ARE PREVALENT ..:

Hong, Simon J. ; Ermann, Joerg ; Dalal, Rahul S....
Gastroenterology. 166 (2024) 5 - p. S-540-S-541 , 2024

Link: https://doi.org/10.1016/..

5

The use of opioids nine months after surgery for Crohn's di..:

Nørgård, Bente Mertz ; Thorarinsson, Caroline Thingholm ; Zegers, Floor Dijkstra...
Alimentary Pharmacology & Therapeutics. 60 (2024) 1 - p. 52-60 , 2024

Link: https://doi.org/10.1111/..

6

247 ONE-YEAR COMPARATIVE EFFECTIVENESS OF UPADACITINIB VERS..:

Dalal, Rahul S. ; Kallumkal, Govind ; Cabral, Heidy..
Gastroenterology. 166 (2024) 5 - p. S-56-S-57 , 2024

Link: https://doi.org/10.1016/..

7

Mo1865 CLINICAL OUTCOMES AT 8-16 WEEKS AFTER UPADACITINIB I..:

Dalal, Rahul S. ; Sasson, Gila ; Gupta, Sanchit...
Gastroenterology. 166 (2024) 5 - p. S-1150-S-1151 , 2024

Link: https://doi.org/10.1016/..

8

Su1722 REAL-WORLD COMPARATIVE EFFECTIVENESS OF UPADACITINIB..:

Dalal, Rahul S. ; Radcliffe, Marlana ; Sninsky, Jared A....
Gastroenterology. 164 (2023) 6 - p. S-651-S-652 , 2023

Link: https://doi.org/10.1016/..

9

949 USE OF TRAMADOL VERSUS TRADITIONAL OPIOIDS AND ADVERSE ..:

Dalal, Rahul S. ; Lund, Ken ; Zegers, Floor...
Gastroenterology. 164 (2023) 6 - p. S-207-S-208 , 2023

Link: https://doi.org/10.1016/..

10

Su1721 ONE-YEAR COMPARISON OF CLINICAL AND ENDOSCOPIC OUTCO..:

Dalal, Rahul S. ; Sharma, Puza P. ; Bains, Kanwal..
Gastroenterology. 164 (2023) 6 - p. S-651 , 2023

Link: https://doi.org/10.1016/..

11

Inpatient Gastroenterology Workups Prior to Transesophageal..:

DALAL, RAHUL S. ; RUBIN, DEBORAH C.
Gastro Hep Advances. 2 (2023) 5 - p. 743-744 , 2023

Link: https://doi.org/10.1016/..

12

1-Year Comparison of Clinical and Endoscopic Outcomes of To..:

Dalal, Rahul S ; Sharma, Puza P ; Bains, Kanwal..
Inflammatory Bowel Diseases. , 2023

Link: https://doi.org/10.1093/..

13

1-Year Comparative Effectiveness of Tofacitinib vs Ustekinu..:

Dalal, Rahul S ; Sharma, Puza P ; Bains, Kanwal..
Inflammatory Bowel Diseases. 30 (2023) 3 - p. 395-401 , 2023

Link: https://doi.org/10.1093/..

14

Excipient Exception: A Complication of Infliximab and Vedol..:

Dalal, Rahul S. ; Goksel, Behiye ; Hamilton, Matthew J.
Digestive Diseases and Sciences. 68 (2023) 5 - p. 1709-1713 , 2023

Link: https://doi.org/10.1007/..

15

Reply: Tofacitinib in Ulcerative Colitis: Beyond Biologics?:

Dalal, Rahul S ; Allegretti, Jessica R
Inflammatory Bowel Diseases. 30 (2023) 3 - p. 516-516 , 2023

Link: https://doi.org/10.1093/..